GLP-1 RECEPTOR AGONISTS HAVING IMPROVED PHARMACOLOGICAL AND DRUG DELIVERY PROPERTIES

GLP-1 RECEPTOR AGONISTS HAVING IMPROVED PHARMACOLOGICAL AND DRUG DELIVERY PROPERTIES

Disclosed are polypeptides, compositions, and methods useful for activating a glucagon-like peptide- 1 (GLP-1) receptor and treating or preventing diseases or disorders at least partially mediated by glucagon-like peptide 1 (GLP-1). L'invention concerne des polypeptides, des compositions et des...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: GRIBKOFF, Valentin, DILLER, David, SWANSON, Jon, SHRIER, Allison, PENTELUTE, Bradley, SAWYER, Jonathon, GUNASEKERA, Dinara, SAWYER, Tomi, AUDIE, Joseph, SANTIAGO, Solimar
Format: Patent
Sprache:eng ; fre
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Disclosed are polypeptides, compositions, and methods useful for activating a glucagon-like peptide- 1 (GLP-1) receptor and treating or preventing diseases or disorders at least partially mediated by glucagon-like peptide 1 (GLP-1). L'invention concerne des polypeptides, des compositions et des méthodes utiles pour activer un récepteur de peptide-1 de type glucagon (GLP-1) et traiter ou prévenir des maladies ou des troubles au moins partiellement médiés par le peptide 1 de type glucagon (GLP-1).